Skip to main content

Advertisement

SpringerLink
Log in

The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Introduction

The appropriate management of advanced ovarian cancer has been controversial in recent years. Lymphatic node involvement is known one of the most important prognostic factors in epithelial ovarian carcinomas. On the other hand in patients with advanced ovarian cancer involving the upper abdomen (with/without lymph node involvement) the evaluation of pelvic and para-aortic lymph nodes does not contribute to the staging and more importantly it does not improve overall-survival.

Materials and methods

One hundred three patients underwent systematic pelvic and para-aortic lymphadenectomy in our clinic. Fifty-three patients with FIGO stage IIIC and IV epithelial ovarian tumor were included in the study. The numbers of positive lymph nodes in each patient were compared with the preoperative CA125 values, positivity/negativity of peritoneal washings and tumor types. Also we compared the patients with positive lymph nodes with patients with negative lymph nodes and investigate differences in CA125 levels, histological types, and cytology.

Results

No significant difference was observed between the patients’ preoperative CA125 values and the number of positive lymph nodes. A significant relation was not determined between the positivity or negativity of peritoneal washings and the number of positive lymph nodes. As a number of positive lymph nodes were compared with the tumor types a significant difference was not observed. On the other hand, statistically, a significant relationship was found between patients with positive lymph nodes and patients with negative lymph nodes in terms of preoperative CA125 values, the positivity or negativity of peritoneal washings and histological types of tumors.

Discussion

We could not determine any effects of preoperative CA125 values, histological type of tumor and peritoneal cytology on the number of positive lymph nodes. Pelvic and para-aortic lymphadenectomy must be performed for us until the factors that affect nodal involvement will be described further in larger and more comprehensive studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boring CC, Squires TS, Tong T (1991) Cancer statistics, 1991. CA Cancer J Clin 41:19–36

    Article  CAS  PubMed  Google Scholar 

  2. Goldstein SR (1996) Postmenopausal adnexal cysts: how clinical management has evolved. Am J Obstet Gynecol 175:1498–1501

    Article  CAS  PubMed  Google Scholar 

  3. Forstner R, Hricak H, Occhipinti KA, Powel CB (1995) Ovarian cancer staging with CT and MR imaging. Radiology 197:619

    CAS  PubMed  Google Scholar 

  4. Griffiths CT (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101–104

    CAS  PubMed  Google Scholar 

  5. Venesmaa P, Ylikorkala O (1992) Morbidity and mortality associated with primary and repeat opeations for ovarian cancer. Obstet Gynecol 79:168–172

    CAS  PubMed  Google Scholar 

  6. Rock J, Howard WH (2005) Te Linde’s operative gynecology. 9th edn, pp 1360–1373

  7. Ayhan A, Gultekin M, Dursun P, Dogan NU, Aksan G, Guven S et al (2008) Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance? Gynecol Oncol 108:428–432

    Article  PubMed  Google Scholar 

  8. Pereira A, Magrina JF, Rey V, Cortes M, Magtibay PM (2007) Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol 105:604–608

    Article  PubMed  Google Scholar 

  9. Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E et al (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97:560–566

    PubMed  Google Scholar 

  10. Ayhan A, Gultekin M, Celik NY, Dursun P, Taskiran C, Aksan G et al (2007) Occult metastasis in early ovarian cancers: risk factors and associated prognosis. Am J Obstet Gynecol 196:81–86

    Article  PubMed  Google Scholar 

  11. Aydin C, Unalp HR, Baloğlu A, Inci AG, Yiğit S, Yavuzcan A (2009) Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature. Arch Gynecol Obstet 279:203–207

    Article  PubMed  Google Scholar 

  12. Harter P, Gnauert K, Hils R, Lehmann TG, Fisseler-Eckhoff A, Traut A et al (2007) Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer 17:1238–1244

    Article  CAS  PubMed  Google Scholar 

  13. Yancik R (1993) Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71:517–523

    CAS  PubMed  Google Scholar 

  14. Merino MJ, Jaffe G (1993) Age contrast in ovarian pathology. Cancer 71:537–544

    CAS  PubMed  Google Scholar 

  15. Katsube Y, Berg JW, Silverberg SG (1982) Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979. Int J Gynecol Pathol 1:3–16

    Article  CAS  PubMed  Google Scholar 

  16. Chiaffarino F, Parazzini F, Bosetti C, Franceschi S, Talamini R, Canzonieri V et al (2007) Risk factors for ovarian cancer histotypes. Eur J Cancer 43:1208–1213

    Article  PubMed  Google Scholar 

  17. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS (2008) Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 109:370–376

    Article  PubMed  Google Scholar 

  18. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody CA125. Int J Gynecol Pathol 2:275–285

    CAS  PubMed  Google Scholar 

  19. Saygili U, Guclu S, Uslu T, Erten O, Demir N, Onvural A (2002) Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma? Gynecol Oncol 86:57–61

    Article  PubMed  Google Scholar 

  20. Ayhan A, Gultekin M, Taskiran C, Celik NY, Usubutun A, Kucukali T et al (2005) Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables. Gynecol Oncol 97:400–404

    Article  PubMed  Google Scholar 

  21. Tsumura N, Sakuragi N, Hareyama H, Satoh C, Oikawa M, Yamada H et al (1998) Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer 79:526–530

    Article  CAS  PubMed  Google Scholar 

  22. Suzuki M, Ohwada M, Yamada T, Kohno T, Sekiguchi I, Sato I (2000) Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol Oncol 79:305–308

    Article  CAS  PubMed  Google Scholar 

  23. Shih IEM, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518

    CAS  PubMed  Google Scholar 

  24. Di Re F, Baiocchi G, Fontanelli R, Grosso G, Cobellis L, Raspagliesi F et al (1996) Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastasis. Gynecol Oncol 62:360–365

    Article  CAS  PubMed  Google Scholar 

  25. Benedetti-Panici P, Greggi S, Maneschi F, Scambia G, Amoroso M, Rabitti C et al (1993) Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 51:150–154

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. First Clinic of Gynecology and Obstetrics, Ataturk Training and Research Hospital, 35820, Izmir, Turkey

    Ali Yavuzcan, Ali Baloglu & Burcu Cetinkaya

Authors
  1. Ali Yavuzcan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Baloglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Burcu Cetinkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Yavuzcan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yavuzcan, A., Baloglu, A. & Cetinkaya, B. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer. Arch Gynecol Obstet 280, 939–944 (2009). https://doi.org/10.1007/s00404-009-1038-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-1038-8

Keywords

Search

Navigation